![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 20, 15498-15503, May 19, 2000
From the Department of Medicine, University of Washington, Seattle, Washington 98195
| |
ABSTRACT |
|---|
|
|
|---|
The heterogeneous nuclear ribonucleoprotein
(hnRNP) K, a component of the hnRNP particles, appears to be
involved in several steps of regulation of gene expression. To gain
insight into mechanisms of K protein action, we performed two-hybrid
screens using full-length hnRNP K as a bait. Several novel protein
partners were identified, including Y-box-binding protein (YB-1),
splicing factors 9G8 and SRp20, DNA-methyltransferase, hnRNP L, and
hnRNP U. In vitro binding studies and
co-immunoprecipitation from cellular extracts provided evidence for
direct interaction between hnRNP K and YB-1. Two distinct domains in
YB-1 were responsible for binding to K protein. Each protein was able
to transactivate transcription from a polypyrimidine-rich promoter;
however, this effect was reduced when K and YB-1 proteins were
coexpressed suggesting a functional interaction between these two proteins.
Activation of gene expression in eukaryotes encompasses multiple
processes including chromatin reorganization, followed by the assembly
of transcription factors onto promoter elements, processing of
pre-mRNA transcripts, and export of the mRNA into the cytoplasm
and translation. Although each of these steps has been intensively
explored, little is known of how these processes are linked and what
factors are involved. RNA-binding proteins, components of the
hnRNP1 particles, may play
such a role (1). The formation of these particles is closely coupled to
transcription. There are over 20 proteins that bind to pre-mRNA,
which are collectively known as the heterogenous nuclear
ribonucleoproteins. These proteins are thought to promote formation of
pre-mRNA secondary structure and can influence splice site
selection. Some hnRNP proteins shuttle between the nucleus and
cytoplasm and potentially can influence mRNA export and
translation. RNA-binding proteins not only associate with nascent
pre-mRNA but also have been found to contact the basal
transcriptional machinery and can directly bind to DNA regulatory elements within the promoter itself (reviewed in Ref. 2). Moreover, recent data suggest that components of hnRNPs may serve as a structural and/or functional link between RNA metabolism and nuclear architecture (3).
The hnRNP K protein, a component of the hnRNP particle, exhibits many
of the functions described above. It has a wide tissue distribution and
is detected in the nucleus and cytoplasm (4). K protein contains both a
classical bipartite-basic nuclear localization signal and the novel K
nuclear shuttling domain that allow it to shuttle between nucleus and
cytoplasm by utilization of one of the two pathways for nuclear entry
(5).
K protein has a strong affinity for polypyrimidine-rich RNA and for
single-stranded DNA. K protein is also known to interact with many
proteins involved in several cellular processes. Because hnRNP K
interacts with many protein kinases such as Src, protein kinases C, and
the proto-oncogene vav (6-8), it has been proposed that
hnRNP K is involved in signal transduction and may act as a "docking
platform" mediating cross-talk between these molecules (9). K protein
may facilitate the ability of other factors to stimulate or repress
transcription by recruiting gene-specific or general components of the
transcription machinery to promoters, such as TBP, SP1, and the
transcriptional repressor, Zik1 (10-12).
In addition to its involvement in signal transduction and
transcription, K protein may participate in the regulation of other nucleic acid-dependent processes. For example, binding of K
protein to Eed (13), a putative silencer of homeotic genes, may reflect participation of hnRNP K in chromatin reorganization. K
protein-mediated silencing of the lipoxygenase mRNA through the
binding to the CU-rich 3'-untranslated region (14) represents an
example of hnRNP K involvement in translation.
Taken together, these studies suggest that K protein is involved in
multiple processes that comprise gene expression and may serve as a
link between signal transduction pathways and nucleic acid-dependent processes (7, 15). To gain more insight
into the mechanisms of K protein action, we performed two-hybrid
screens using full-length hnRNP K as a bait. We identified several
novel protein partners, including YB-1 transcription factor,
splicing factors 9G8 and SRp20, DNA-methyltransferase, hnRNP L, and
hnRNP U. In this work we describe the interaction between K protein and
YB-1, another multifunctional protein.
Plasmids--
For two-hybrid analyses, cDNA encoding
full-length K protein was inserted into multiple cloning sites of
plasmid pGBT9, which expresses the Gal4 DNA binding domain
(CLONTECH). In frame fusion was verified by
sequencing using the DyeDeoxy terminator cycle sequencing kit (PE
Applied Biosystems) and by in vitro
transcription/translation analysis. Two cDNA libraries were used in
the two-hybrid screen. The mouse cDNA library was generated by
random-primed cDNA synthesis from a 9-10-day-old mouse embryo (Dr.
S. Hollenberg) and size-selected for inserts in the range of 350-700
nucleotides. This library was inserted into the transcription
activation domain vector, pVP16, to generate VP16-cDNA hybrid
proteins. The Jurkat cell cDNA library of Gal4AD-cDNA fusion
for the two-hybrid screen was obtained from
CLONTECH.
Construction of the GST·K mutants was described previously (6).
EFIA/YB-1 cDNA was kindly provided by Dr. K. R. Chen. For the in vitro experiments the NotI
fragment carrying full-length EFIA/YB-1 cDNA was
subcloned into the NotI site of pBluescript II SK
(Stratagene), and the resulting plasmid was denoted pSK-YB-1. To create
the YB-1 C mutant, pSK-YB-1 was digested with SalI and religated. The NotI/SalI fragment was isolated
and inserted into the NotI/SalI sites of pET28a.
The 0.7-kilobase SalI fragment from pSK-YB-1 containing the
N terminus of EFIA/YB-1 was subcloned into the
SalI site of the pSK vector. This mutant was named YB-1 NI.
The NII, cold shock domain (CSD), NIII, CI, and CII fragments were
created by polymerase chain reaction and subcloned into pET28a vector
(Fig. 5). All constructs were verified by sequencing.
Flag-YB-1 was generated by insertion of YB-1 cDNA into the
EcoRI/XhoI sites of p18-Flag mammalian expression vector.
PSG5-K and pSG 5 was a gift from Dr. A. Ostareck-Lederer. pSG 5-YB-1
was created by inserting the NotI fragment of
EFIA/YB-1 into pSG5.
The plasmids pgst-TBP, p Yeast Strains, Transformation, and Growth
Conditions--
Transformation of yeast cells was carried out by the
method of Klebe et al. (16). Yeast transformants were
selected and cultivated on SD synthetic medium (2% glucose and 0.67%
yeast nitrogen base without amino acids) supplemented with essential amino acids and nucleotides.
The yeast strain HF7C (MATa, ura3-52, his3-200, lys2-801,
ade2-101, trp1-901, leu2-3, 112, gal4-542, gal80-538,
LYS2::GAL-HIS3, URA3::(GAL4
17-mers)3-CYC1-LacZ) was used to perform primary
screening. Histidine prototroph clones were assayed for
Synthesis and Purification of GST Fusion Proteins--
GST·K
and GST·TBP constructs were described previously (6, 7).
In vitro transcription and translation was performed using
the TNT T7 Quick coupled transcription/translation system as per the
manufacturer's protocol (Promega, Madison, WI).
In Vitro Binding Studies--
2.5 µl of the
35S-labeled products were added to a suspension of 20 µl
of glutathione or 10 µl of either poly(A), (C), (G), (U), or (I)
beads in 100 µl of binding buffer (12). After mixing for 60 min
(4 °C), the beads were washed three times with 400 µl of binding
buffer and then boiled with 30 µl of SDS loading buffer; proteins
were separated by SDS-polyacrylamide gel electrophoresis (PAGE) and
detected by autoradiography.
Transient Transfections--
HeLa cells were grown in
Dulbecco's minimal essential medium supplemented with 10% fetal
bovine serum in 60- or 100-mm dishes and were transfected using
SuperFect Transfection Reagent as per the manufacturer's protocol
(Qiagen). Either pRLnull plasmid (Promega) encoding Renilla
luciferase or pSVgal plasmid (Promega) encoding
Cell extracts were prepared by a modified version of the method of
Dignam et al. (18) as described previously (7). Protein concentration was measured using the DC method (Pierce).
Immonoprecipitation and Western Blotting--
Transfected HeLa
cells were grown for 48 h, and cell extracts were prepared as
described above. Rabbit polyclonal anti-K protein antibody 54 was added
to 500 µl of cell extract, and the mixture was incubated overnight at
4 °C with low speed rotation. 20 µl of protein A/G PLUS-agarose
(Santa Cruz Biotechnology Inc.) and ELB buffer (19) (250 mM
NaCl, 0.1% Nonidet P-40, 50 mM HEPES (pH 7.0), 5 mM EDTA) were added to a total volume of 1 ml. The mixture
was rotated for another hour at 4 °C. The protein A/G beads were
washed four times with 1 ml of ELB buffer, and the proteins were eluted
by boiling in 30 µl 1× loading buffer, separated by SDS-PAGE, and
transferred to Immobilon-P membrane (Millipore). The blots were probed
with monoclonal M2 anti-Flag antibodies (Sigma). The chemiluminescent
detection was performed with ECL Western blotting detection reagents
according to standard protocol (Amersham Pharmacia Biotech).
Identification of New Protein Partners of K Protein Using the Yeast
Two-hybrid System--
Although recent data indicate that hnRNP K
protein is involved in many cellular processes, the mechanism of its
action is largely unexplored. Thus the identification of new protein
partners of K protein provides important information about its cellular function. We performed a two-hybrid screen with full-length K as a bait
using two cDNA libraries. The Gal4BD·K fusion protein did not
have transactivation activity by itself when expressed in
Saccharomyces cerevisiae. Yeast strain HF7C expressing
Gal4BD·K protein was transformed with 9-10-day-old mouse embryo or
Jurkat cell cDNA library; transformants were selected as described
under "Materials and Methods." Putative positive clones were
retransformed into SFY526 yeast strain and tested for the expression of
K Protein Interacts with YB-1 in Vitro--
To confirm the
two-hybrid screen we examined whether YB-1 could interact with K
protein in vitro. In these experiments we used the rat
homologue of YB-1, EFIA. In vitro translated
35S-labeled YB-1 was incubated with agarose beads bearing
GST·K protein, as described previously (7). After incubation, beads were washed three times with an excess of binding buffer and one time
with the same buffer containing 1% Nonidet P-40. Samples were boiled
in SDS loading buffer, and proteins were resolved by SDS-PAGE. In
agreement with the two-hybrid screen, a strong interaction between YB-1
and GST·K was observed in vitro (Fig. 2A, lane 2). In
contrast to the mammalian K protein, the yeast homolog of hnRNP K,
PBP2p (20), did not interact with YB-1 (Fig. 2A, lane
1). Of note, the YB-1 family proteins are not represented in the
yeast genome (confirmed by a search of the completed yeast genome
sequence). For some RNA-binding proteins it is known that RNA mediates
protein-protein interaction. For example, the primary steps of Sam68
dimerization require cellular RNA (21). Because both K and YB-1 are
known to be RNA-binding proteins, we next tested whether the
interaction between these proteins can be mediated by RNA. We performed
the binding experiments in the presence of RNase and found no change in
the strength of binding of YB-1 to GST·K (data not shown). This
indicates that YB-1 interacts with hnRNP K directly; however, the
possibility that RNA regulates this interaction cannot be excluded. To
test this possibility, the binding of 35S-labeled YB-1 to
GST·K was performed in the presence of several homopolymeric RNAs,
poly(A), (C), (G), (I), and (U) (Fig. 2B, lanes
1-5). These experiments were carried out in two different ways.
In one set of experiments, 35S-labeled YB-1 and GST·K
beads were incubated in the presence of polynucleotides; in another
set, GST·K beads were preincubated with polynucleotides for 30 min
before 35S-labeled YB-1 was added to the reaction mixture.
Identical results were obtained in both experiments. As shown in Fig.
2B (lane 1), poly(U) decreased the interaction of
YB-1 with K protein, whereas the other polynucleotides did not alter
this binding. When incubated under the same binding conditions, but
without K protein, YB-1 was able to bind poly(U) and poly(G) beads
(data not shown).
Mapping the Regions of K Protein Involved in Interaction with
YB-1--
Using a panel of GST·K deletion mutants, we next mapped
the interaction region in hnRNP K responsible for binding to YB-1. As
shown in Fig. 3, 35S-labeled
YB-1 strongly interacted with GST·K13 (lane 6) and
GST·K31 (lane 8), but no binding was detected with the
other mutants. These data indicate that the interactive region is
located between amino acids 240 and 337. This region, denoted KI, was
previously found to be responsible for binding of other K protein
partners such as protein kinase C
Levens and co-workers (10) demonstrated the interaction between TBP and
K in vitro and in vivo. In contrast to YB-1, we observed strong interaction of 35S-labeled TBP not only
with GST·K31 and GST·K13 but also with GST·K7 (Fig.
4, lanes 3, 6, and
8) and moderate binding to GST·K10 (Fig. 4, lane
4) indicating that the only amino acids overlapping the strongest
binding fragments are 318-337, but amino acids external to this region
also impact TBP binding.
To more precisely map the region of K protein responsible for binding
to YB-1, we used GST·K protein mutants with deletions inside the KI
region. Deletions of amino acids 322-337 and 288-321 abolished
binding to 35S-labeled YB-1 (data not shown). Thus KI
(amino acids 240-337) is the minimal region responsible for hnRNP
K-YB-1 interaction.
To map the interactive region in YB-1 that binds K protein, we created
a series of deletion mutants (Fig.
5C). The in vitro binding experiments were performed as described above. Surprisingly, we
observed equally strong binding of both N-terminal and C-terminal parts
of YB-1, indicating the presence of multiple interactive regions (Fig.
5, A and B). The binding of NII polypeptide
(amino acids 58-150), which includes the conservative RNA binding CSD followed by 26 amino acids, was as strong as that of the full-length YB-1 (Fig. 5A, lanes 7). As shown in Fig.
5A, the NIII polypeptide, containing 26 amino acids
immediately downstream of the CSD, maintained a strong interaction with
GST·K (Fig. 5A, lane 9). No interaction was
found with the "cold shock" domain (Fig. 5A, lane
8).
Fig. 5B illustrates mapping of the second interactive region
localized in the C terminus of YB-1. The CI polypeptide did not interact with GST·K protein (lane 11); however, the
binding of the CII polypeptide containing the amino acids 271-320 was
strong (lane 12). Thus the second interactive region
responsible for binding to GST·K is located in the last 50 amino
acids of the C terminus of YB-1 (amino acids 271-320).
These results are in agreement with our two-hybrid system data. As
shown in Fig. 1, the highest
Next, we examined whether TATA-binding protein, a known partner of
hnRNP K, can interact with YB-1. As in the case of GST·K, the same
NIII (amino acids 124-150) (Fig. 5A, lane 6) and
CII (amino acids 271-320) polypeptides (Fig. 5B, lane
6) were responsible for the binding of YB-1 to TBP.
Co-immunoprecipitation of K Protein and YB-1 from Cell
Extracts--
Because the hnRNP K is highly expressed in HeLa cells,
we tested whether endogenous K protein can interact with overexpressed Flag-tagged YB-1. HeLa cells were transfected with Flag- YB-1 construct. Cellular extracts were prepared and examined for the presence of K protein·YB-1 complex by co-immunoprecipitation with either pre-immune or anti-K serum followed by Western blotting with
anti-Flag antibodies (as described under "Materials and Methods"). In cells transfected with Flag-YB-1 only immune anti-K serum
precipitated Flag-YB-1 (Fig. 5, lane 4). Although expression
levels of both hnRNP K (4) and Flag- YB-1 are high (lanes 7 and 8), the magnitude of their detectable interaction
appears to be lower than expected. This could be explained by the fact
that both K protein and YB-1 have many other molecular partners.
The Role of K Protein-YB-1 Interaction in Gene Expression--
One
of the functional similarities between hnRNP K and YB-1 is their high
affinity binding to single-stranded polypyrimidine-rich sequences. K
protein and YB-1 have been shown to interact with a C-rich DNA
sequence, termed the CT element upstream of the c-myc gene
(24, 25). Furthermore, overexpressed hnRNP K and TBP synergistically
activated transcription of a CT element-dependent reporter
gene in vivo (10). Recent studies revealed that the chicken
homolog of YB-1 protein, chk-YB-1b, binds efficiently to the well
conserved polypyrimidine tract found in
Because hnRNP K and YB-1 exhibit transcriptional activities from the
sequence CCCTCCCCA, known as the CT element of the human c-myc gene (10, 24, 25), we tested how the coexpression of K
and YB-1 proteins affects the activity of a luciferase reporter gene.
HeLa cells were transfected with hnRNP K and Flag-tagged YB-1
expression constructs and with a plasmid encoding the luciferase reporter gene driven by a synthetic promoter containing three repeats
of the CT element of either wild-type CT3 or a mutated version, CT3mut,
upstream of the minimal c-fos promoter described in Ref. 10.
As shown in Fig. 7A, hnRNP K
alone did not have an effect on the luciferase expression level. Flag-
YB-1 slightly activated transcription from the CT3 wild type promoter
element but did not affect transcription from the promoter-containing mutated CT3 element. When both proteins were coexpressed in HeLa cells,
the activation effect of YB-1 from the wild-type CT3 element was
reduced. Similar results were obtained in NIH3T3 cells (Fig. 7B). YB-1 activated transcription from the wild type
promoter but not from the mutant. Interestingly, in this cell line
hnRNP K also activated the CT element in a sequence-specific manner. The sequence-specific trans-activation effect of both K protein and
YB-1 was reduced when both proteins were coexpressed. These transfection experiments show that hnRNP K and YB-1 are functionally linked. It should be noted, however, that both proteins had only a
modest effect on the expression of the reporter gene. As mentioned above, K and YB-1 proteins are abundant, and the high level of the
endogenous proteins may have blunted the reporter gene
expression.
In this paper we describe the interaction between K protein and
YB-1. There are many indications that hnRNP K and YB-1 are functionally
similar proteins. As described in the Introduction, K protein is
involved in many steps of transcriptional regulation, interacting with
general and sequence-specific transcription factors, and binding
sequence-specific polypyrimidine-rich DNA motifs within promoter
regions. It has been proposed that K protein acts as a scaffold or
architectural transcription factor that promotes assembly of
sequence-specific transcription factors and basal transcription
machinery on the promoter elements (10). YB-1 protein possesses similar
functional properties. It has been shown to modulate transcription
through binding single-stranded polypyrimidine-rich DNA sequences and
by interacting with transcription factors (10-12). Like K, protein
YB-1, is known to be involved in repressing and activating
transcription (11, 27). YB-1 is thought to activate transcription of
human polyomavirus JC by recruiting another trans-activator (p65 or
RelA) to the viral promoter (28). YB-1 can act on a single gene, the
matrix metalloproteinase 2 gene, in a positive or negative manner that
is dependent upon the cellular context (29). The reported
transcriptional activity of YB-1 protein is strongly dependent on the
intracellular environment. For example, the synergistic activity of
YB-1 and Pur Both proteins have multiple interactive domains. K protein contains two
different types of nucleic acid binding domains, the KH domains and the
RGG cluster, and the KI region responsible for protein-protein
interaction. The same is true for YB-1. Safak et al. (23)
have shown that YB-1 protein interacts through the region that includes
the entire cold shock RNA binding domain with the transcription factor
Pur These data indicate that K and YB-1 proteins may simultaneously
interact with more than one of their partners to form multiple protein
or protein·nucleic acid complexes. It is further plausible that the
interaction of YB-1-hnRNP K with one of their partners (nucleic acid
and proteins) may serve to regulate the interaction with another
partner. For example, as shown in Fig. 2B (lane
1) the interaction with poly(U) abolished the binding of K to
YB-1.
When both YB-1 and hnRNP K proteins are coexpressed their
transcriptional activity is reduced. HnRNP K and YB-1 interact in vitro with the general transcription factor TATA-binding protein (Figs. 4 and 5). It has been suggested that TBP-mediated activation of
transcription can be regulated by a variety of gene-specific transcription factors (31). As shown previously, cotransfection of K
protein and TBP resulted in activation of transcription from the
CT-rich promoter element (10). Our preliminary findings indicate that
coexpression of YB-1 and TBP has the same
effect on the CT-rich promoter element.2 In
vitro data show that YB-1 binds K protein and TBP through the same
domains (Fig. 5), suggesting that the two factors may compete for YB-1.
We propose that gene-specific activation of transcription, particularly
from the CT element containing promoters, may be activated by
increasing concentration of either hnRNP K·TBP or YB-1·TBP
complexes explaining the increased reporter gene expression when either
K or YB-1 was transfected. Coexpression of K and YB-1 proteins may
favor formation of K·YB-1 complexes, which might be transcriptionally
inactive, accounting for the decreased reporter gene expression. A
similar effect has been shown for Sp1 and C/EBP In summary, we show interaction between two functionally similar
factors hnRNP K and YB-1. Because both proteins are involved in many
steps of gene expression such as transcription, translation, and
nuclear transport it is plausible that these processes are regulated by
the interaction of hnRNP K and YB-1. Future studies will be designed to
address this issue.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
56CT3wt, and p
56CT3mut were a gift from
Dr. D. Levens. CT3wt-c-fos and CT3mut-c-fos
promoter elements were cut out from p
56CT3wt and p
56CT3mut,
respectively, and subcloned into the pGL3-basic vector (Promega). All
plasmids were purified using the QIAfilter Plasmid Maxi Kit (Qiagen).
-galactosidase activity by a filter assay. Positive clones were then
transformed into the yeast strain SFY526 (MATa, ura3-52,
his3-200, ade2-101, lys2-801, trp1-901, leu2-3, 112, canr, gal4-542, gal80-538,
URA3::GAL1-LacZ) and tested for
-galactosidase activity.
-galactosidase expression was detected either by qualitative
determination using a filter lift assay (17) with
5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside as a
substrate or quantitatively by
o-nitrophenyl-
-D-galactopyranoside hydrolysis
measured photometrically at 420 nm upon permeabilization of cells (17).
The enzymatic activity was normalized to cell culture density expressed
as arbitrary units.
-galactosidase was
cotransfected to normalize transfection efficiency. The same protocol
was used to transfect NIH3T3 cells. Luciferase activity assay was
performed according standard protocols (Promega).
-Galactosidase
activity was measured using a Galacto-light plus chemiluminescent
reporter assay system (Tropix).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-galactosidase. False positives were excluded by their ability to
activate transcription of His and lacZ reporter
genes in the absence of the bait. Sequencing of twenty-one true
positive clones from the mouse cDNA library identified several new
protein partners of hnRNP K (Table I). Screening of the Jurkat cDNA library yielded two true positive clones encoding hnRNP L, a component of hnRNP, and the pre-mRNA splicing factor SRp 20. The interaction with splicing factors and hnRNP
L suggests that K protein participates in the processing of
pre-mRNA. Interaction with scaffold factors and
DNA-methyltransferase may reflect the role of K protein in chromatin
organization. Seven clones represented YB-1 cDNA with different
lengths of insert and different strength of interaction with the
bait (Fig. 1). We were particularly
interested in YB-1 protein because it shares many functional
similarities with hnRNP K and appears to be involved in many cellular
processes.
Identification of hnRNP K binding proteins by two-hybrid screen

View larger version (23K):
[in a new window]
Fig. 1.
YB-1 interacts with hnRNP K in S. cerevisiae two-hybrid system. A, schematic
representation of modular domains of YB-1 protein. Numbers
represent amino acid residues. B, plasmid containing partial
cDNA of mouse YB-1 fused to the VP-16 activation domain was rescued
from seven true positive clones from the yeast strain HF7c and then
retransformed into S. cerevisiae SFY 526. Quantitative
-galactosidase activity was monitored as described under
"Materials and Methods." The enzymatic activity was normalized to
cell culture density and is expressed as arbitrary units.

View larger version (25K):
[in a new window]
Fig. 2.
K protein interacts with YB-1 in
vitro. A, GST·K and GST·PBP2p bound to
glutathione beads were incubated with 2.5 µl of in vitro
translated 35S-labeled YB-1. Beads were washed three times
with binding buffer and one time with binding buffer containing 1%
Nonidet P-40. Proteins bound to the beads were eluted with SDS buffer
as described under "Materials and Methods" and then resolved by
SDS-10% PAGE. The gel was stained (Coomassie Blue) and
autoradiographed. 2.5 µl of the input (load) used in each reaction
was run in lane 3. The arrow marks the position
of the in vitro translated 35S-labeled YB-1.
B, GST·K protein bound to glutathione beads was incubated
with in vitro translated 35S-labeled YB-1 in the
absence (lane 6) or presence of 2 µg of given homopolymer
RNA (lanes 1-5). Beads were washed, and bound proteins were
eluted and analyzed as described above.
, Zik1, and Eed (7, 12, 13).

View larger version (40K):
[in a new window]
Fig. 3.
Mapping of K protein domain responsible for
binding to YB-1. GST·K mutants (A) were incubated
with in vitro translated 35S-labeled YB-1. Beads
were washed three times with binding buffer, and bound proteins were
eluted with SDS buffer as described under "Materials and Methods"
and then resolved by SDS-10% PAGE. 30% of the input used in each
reaction (load) was run in lane 9. The arrow
marks the position of the in vitro translated
35S-labeled YB-1. The gels were stained (Coomassie Blue)
and autoradiographed (B).

View larger version (40K):
[in a new window]
Fig. 4.
Mapping of K protein domain responsible for
binding to TBP. The GST·K mutants (A) bound to
glutathione beads were incubated with the in vitro
translated 35S-labeled TBP. The beads were washed three
times with binding buffer, and bound proteins were eluted with SDS
loading buffer as described under "Materials and Methods" and were
resolved by SDS-10% PAGE. 30% of the input used in each reaction was
run in lane 9. The arrow marks the position of
in vitro translated 35S-labeled TBP. The gels
were stained (Coomassie Blue) and autoradiographed
(B).

View larger version (33K):
[in a new window]
Fig. 5.
Mapping YB-1 regions interacting with
GST·hnRNP K and GST·TBP. A, the GST·K and
GST·TBP proteins bound to glutathione beads were incubated with 2.5 µl of in vitro translated 35S-labeled YB-1
deletion mutants (NI, CSD, and NIII). Beads were washed, and bound
proteins were eluted as described under "Materials and Methods."
Proteins were resolved by SDS-15% PAGE. 2.5 µl of the input
(load) used in each reaction was run in lanes
1-3. The binding of NII (lanes 4 and 7) and
NIII polypeptides (lanes 6 and 9) to GST·TBP
and GST·K was strong. No interaction was found with the cold shock
domain (lanes 5 and 8). B, the GST·K
and GST·TBP proteins bound to glutathione beads were incubated with
2.5 µl of in vitro translated YB-1 35S-labled
C-terminal mutants (C, CI, and CII). Binding reaction was performed as
described above, and proteins were resolved by SDS-15% PAGE. 2.5 µl
of the input (load) used in each reaction was run in
lanes 1-3. CI polypeptide did not interact with either
GST·TBP (lane 5) or GST·K (lane 11); however,
the binding of CII polypeptide (lanes 12 and 6)
was as strong as that of a mutant (C) containing the entire
C terminus of YB-1 (lanes 4 and 10).
C, schematic representation of YB-1 deletion mutants used in
in vitro binding experiments.
-galactosidase activity was observed
with clones 1 and 2, which contained residues located just downstream
of the cold shock domain. Clone 5 had the part of the C-terminal
interactive region resulting in an increase of
-galactosidase
activity in comparison to clones 3 and 4, which are missing this
C-terminal region. The middle part of YB-1 has been shown to be
responsible for its multimerization and for binding to other protein
partners of YB-1 (22, 23). The presence of two distinct interactive
regions for K protein in YB-1 is a novel observation.
1(I) collagen gene promoter
from rat, mouse, human, and chicken (26). Thus the promoters
containing CT-rich elements could be an appropriate system to
understand the significance of hnRNP-K-YB-1 interaction (Fig.
7).

View larger version (19K):
[in a new window]
Fig. 6.
Co-immunoprecipitation of K protein and YB-1
from cell extracts. Extracts from HeLa cells transfected with
either Flag or Flag-YB-1 plasmids were immunoprecipitated
(IP) with either preimmune (lanes 1 and
2) or immune anti-K protein serum 54 (lanes 3 and
4). Proteins were separated on SDS-PAGE and transferred to
Immobilon-P membrane. Blots were probed with anti-K protein antibody
54.

View larger version (29K):
[in a new window]
Fig. 7.
Functional interaction between K protein and
YB-1 revealed by their effect on a CT element containing promoter.
A, HeLa cells were co-transfected with 2.25 µg of hnRNP K
and 2.25 µg of Flag-YB-1 expression vectors and either 0.25 µg of
wild type CT3wt-c-fos or mutated CT3 mut-c-fos
reporter construct. 0.25 µg of pSV-gal was cotransfected to normalize
transfection efficiency. Data are shown as mean ± standard
deviation from three independent experiments. B,
NIH3T3 were cotransfected with 1.6 µg of hnRNP K and 1.6 µg
of YB-1 expression vectors together with 1.6 µg of either
CT3wt-c-fos or CT3 mut-c-fos. 0.25 µg of pRL
null plasmid was cotransfected to normalize transfection efficiency.
Data are shown as mean ± standard deviation from three
independent experiments with different plasmid
preparations.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
proteins on the JCV enhancer-promoter region has been
observed in glial cells but was not detected in other cell lines (23).
The transactivation properties of YB-1 on myosin light chain 2v gene
promoter have been shown in cardiac myocytes, where the expression of
YB-1 resulted in a 3.4 higher reporter gene activity in comparison to
the control, but no activation was detected in COS-1 cells (30). A
moderate level of transcription activation of matrix
metalloproteinase-2 promoter by YB-1 was observed in mesangial cells
but not in glomerular epithelial cells (29). Taken together, these data
and our transfection experiments (Fig. 7) clearly show that
transcriptional activity of hnRNP K and YB-1 is cell
type-dependent. Both proteins are likely acting as
scaffolds or docking platforms for multiprotein complexes that include
transcription factors. Acting as docking platforms, they may respond to
changes in extracellular environment at sites of nucleic acid-dependent
processes (7, 15).
. Our data indicate that the N-terminal interactive domain
(NIII) in YB-1 responsible for K protein binding overlaps with the Pur
binding region but does not include the cold shock domain.
Moreover, the CII peptide, which has a strong affinity for hnRNP K and
TBP (Fig. 5B, lanes 6 and 12), does
not bind Pur
(23).
transcription
factors where the interaction with K protein abolished their
trans-activation ability (11, 32).
| |
FOOTNOTES |
|---|
* This work was supported by National Institutes of Health Grants GM 45134 and DK 45978, the American Diabetes Association, and the Northwest Kidney Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Medicine, Box
356521, University of Washington, Seattle, WA 98195. Tel.: 206-543-3792; Fax: 206-685-8661; E-mail:
karolb@u.washington.edu.
2 M. Shnyreva, D. S. Schullery, H. Suzuki, Y. Higaki, and K. Bomsztyk, unpublished data.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: hnRNP, heterogeneous nuclear ribonucleoprotein; TBP, TATA-binding protein; GST, glutathione S-transferase; CSD, cold shock domain; PAGE, polyacrylamide gel electrophoresis; YB, Y-box.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Ladomery, M. (1997) Bioessays 19, 903-909[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Wolffe, A. P., and Meric, F. (1996) Int. J. Biochem. Cell Biol. 28, 247-257[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Gohring, F., Schwab, B. L., Nicotera, P., Leist, M., and Fackelmayer, F. O. (1997) EMBO J. 16, 7361-7371[CrossRef][Medline] [Order article via Infotrieve] |
| 4. |
Matunis, M. J.,
Michael, W. M.,
and Dreyfuss, G.
(1992)
Mol. Cell. Biol.
12,
164-171 |
| 5. | Michael, W. M., Eder, P. S., and Dreyfuss, G. (1997) EMBO J. 16, 3587-3598[CrossRef][Medline] [Order article via Infotrieve] |
| 6. |
Van Seuningen, I.,
Ostrowski, J.,
Bustelo, X. R.,
Sleath, P. R.,
and Bomsztyk, K.
(1995)
J. Biol. Chem.
270,
26976-26985 |
| 7. |
Schullery, D. S.,
Ostrowski, J.,
Denisenko, O. N.,
Stempka, L.,
Shnyreva, M.,
Suzuki, H.,
Gschwendt, M.,
and Bomsztyk, K.
(1999)
J. Biol. Chem.
274,
15101-15109 |
| 8. | Bustelo, X. R., Suen, K.-L., Michael, W. M., Dreyfuss, G., and Barbacid, M. (1995) J. Biol. Chem. 15, 1324-1332 |
| 9. | Bomsztyk, K., Van Seuningen, I., Suzuki, H., Denisenko, O., and Ostrowski, J. (1997) FEBS Lett. 403, 113-115[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Michelotti, E. F., Michelotti, G. A., Aronsohn, A. I., and Levens, D. (1996) Mol. Cell. Biol. 16, 2350-2360[Abstract] |
| 11. |
Du, Q.,
Melnikova, I. N.,
and Gardner, P. D.
(1998)
J. Biol. Chem.
273,
19877-19883 |
| 12. |
Denisenko, O. N.,
O'Neil, B.,
Ostrowski, J.,
Van Seuningen, I.,
and Bomsztyk, K.
(1996)
J. Biol. Chem.
271,
27701-27706 |
| 13. | Denisenko, O. N., and Bomsztyk, K. (1997) Mol. Cell. Biol. 17, 4707-4717[Abstract] |
| 14. | Ostareck, D. H., Ostareck-Lederer, A., Wilm, M. B., Thiele, J., Mann, M., and Hentze, M. W. (1997) Cell 89, 597-606[CrossRef][Medline] [Order article via Infotrieve] |
| 15. |
Ostrowski, J.,
Schullery, D. S.,
Denisenko, O. N.,
Higaki, Y.,
Watts, J.,
Aebersold, R.,
Stempka, L.,
Gschwendt, M.,
and Bomsztyk, K.
(2000)
J. Biol. Chem.
275,
3619-3628 |
| 16. | Klebe, R. J., Harris, J. V., Sharp, Z. D., and Douglas, M. G. (1983) Gene (Amst.) 25, 333-341[CrossRef][Medline] [Order article via Infotrieve] |
| 17. | Breeden, L., and Nasmyth, K. (1987) Cell 48, 389-397[CrossRef][Medline] [Order article via Infotrieve] |
| 18. |
Dignam, J. D.,
Lebovitz, R. M.,
and Roeder, R.
(1983)
Nucleic Acids Res.
11,
1475-1489 |
| 19. |
Sewalt, R. G. A. B.,
van der Vlag, J.,
Gunster, M. J.,
Hamer, K. M.,
den Blaauwen, J. L.,
Satijn, D. P. E.,
Hendrix, T.,
van Driel, R.,
and Otte, A. P.
(1998)
Mol. Cell. Biol.
18,
3586-3595 |
| 20. |
Delling, U.,
Raymond, M.,
and Schurr, E.
(1998)
Antimicrob. Agents Chemother.
42,
1034-1041 |
| 21. | Chen, T., Damaj, B. B., Herrera, C., Lasko, P., and Richard, S. (1997) Mol. Cell. Biol. 17, 5707-5718[Abstract] |
| 22. | Tafuri, S. R., and Wolfe, A. P. (1991) New Biol. 4, 349-359 |
| 23. |
Safak, M.,
Gallia, G. L.,
and Khalili, K.
(1999)
Mol. Cell. Biol.
19,
2712-2723 |
| 24. |
Takimoto, M.,
Tomonaga, T.,
Matunis, M.,
Avigan, M.,
Krutzsch, H.,
Dreyfuss, G.,
and Levens, D.
(1993)
J. Biol. Chem.
268,
18249-18258 |
| 25. |
Kolluri, R.,
Torrey, T. A.,
and Kinniburgh, A. J.
(1992)
Nucleic Acids Res.
20,
111-116 |
| 26. | Dhalla, A. K., Ririe, S. S., Swamynathan, S. K., Weber, K. T., and Guntaka, R. V. (1998) Biochem. J. 336, 373-379 |
| 27. |
Swamynathan, S. K.,
Nambiar, A.,
and Guntaka, R. V.
(1998)
FASEB J.
12,
515-522 |
| 28. | Raj, G. V., Safak, M., MacDonald, G. H., and Khalili, K. (1996) J. Virol. 70, 5944-5953[Abstract] |
| 29. |
Mertens, P. R.,
Harendza, S.,
Pollock, A. S.,
and Lovett, D. H.
(1997)
J. Biol. Chem.
272,
22905-22912 |
| 30. | Zou, Y., and Chien, K. R. (1995) Mol. Cell. Biol. 15, 2972-2982[Abstract] |
| 31. | Wu, S-Y., Kershnar, E., and Chiang, C.-M. (1998) EMBO J. 17, 4478-4490[CrossRef][Medline] [Order article via Infotrieve] |
| 32. |
Miau, L.-H.,
Chang, C.-J.,
Shen, B.-J.,
Tsai, W.-H.,
and Lee, S.-C.
(1998)
J. Biol. Chem.
273,
10784-10791 |
This article has been cited by other articles:
![]() |
L. G. Wang, E. M. Johnson, Y. Kinoshita, J. S. Babb, M. T. Buckley, L. F. Liebes, J. Melamed, X.-M. Liu, R. Kurek, L. Ossowski, et al. Androgen Receptor Overexpression in Prostate Cancer Linked to Pur{alpha} Loss from a Novel Repressor Complex Cancer Res., April 15, 2008; 68(8): 2678 - 2688. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Wei, S.-L. Zhang, Y.-W. Chen, D.-F. Guo, J. R. Ingelfinger, K. Bomsztyk, and J. S. D. Chan Heterogeneous Nuclear Ribonucleoprotein K Modulates Angiotensinogen Gene Expression in Kidney Cells J. Biol. Chem., September 1, 2006; 281(35): 25344 - 25355. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yoo, X. Wu, C. Egile, R. Li, and J.-L. Guan Interaction of N-WASP with hnRNPK and Its Role in Filopodia Formation and Cell Spreading J. Biol. Chem., June 2, 2006; 281(22): 15352 - 15360. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. De Celle, F. Vanrobaeys, P. Lijnen, W. M. Blankesteijn, S. Heeneman, J. Van Beeumen, B. Devreese, J. F. M Smits, and B. J. A Janssen Alterations in mouse cardiac proteome after in vivo myocardial infarction: permanent ischaemia versus ischaemia-reperfusion Exp Physiol, July 1, 2005; 90(4): 593 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Malik and J. B. Clements Protein kinase CK2 phosphorylation regulates the interaction of Kaposi's sarcoma-associated herpesvirus regulatory protein ORF57 with its multifunctional partner hnRNP K Nucleic Acids Res., October 14, 2004; 32(18): 5553 - 5569. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. BEDARD, B. L. WALTER, and B. L. SEMLER Multimerization of poly(rC) binding protein 2 is required for translation initiation mediated by a viral IRES RNA, August 1, 2004; 10(8): 1266 - 1276. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Choi, J. H. Kim, X. Li, K. Y. Paek, S. H. Ha, S. H. Ryu, E. Wimmer, and S. K. Jang Identification of cellular proteins enhancing activities of internal ribosomal entry sites by competition with oligodeoxynucleotides Nucleic Acids Res., February 23, 2004; 32(4): 1308 - 1317. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Persson, A. Skalweit, R. Mrowka, and B.-J. Thiele Control of renin synthesis Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2003; 285(3): R491 - R497. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ostrowski, Y. Kawata, D. S. Schullery, O. N. Denisenko, and K. Bomsztyk Transient recruitment of the hnRNP K protein to inducibly transcribed gene loci Nucleic Acids Res., July 15, 2003; 31(14): 3954 - 3962. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Raffetseder, B. Frye, T. Rauen, K. Jurchott, H.-D. Royer, P. L. Jansen, and P. R. Mertens Splicing Factor SRp30c Interaction with Y-box Protein-1 Confers Nuclear YB-1 Shuttling and Alternative Splice Site Selection J. Biol. Chem., May 9, 2003; 278(20): 18241 - 18248. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Miriami, H. Margalit, and R. Sperling Conserved sequence elements associated with exon skipping Nucleic Acids Res., April 1, 2003; 31(7): 1974 - 1983. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Skalweit, A. Doller, A. Huth, T. Kahne, P. B. Persson, and B.-J. Thiele Posttranscriptional Control of Renin Synthesis: Identification of Proteins Interacting With Renin mRNA 3'-Untranslated Region Circ. Res., March 7, 2003; 92(4): 419 - 427. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ashizuka, T. Fukuda, T. Nakamura, K. Shirasuna, K. Iwai, H. Izumi, K. Kohno, M. Kuwano, and T. Uchiumi Novel Translational Control through an Iron-Responsive Element by Interaction of Multifunctional Protein YB-1 and IRP2 Mol. Cell. Biol., September 15, 2002; 22(18): 6375 - 6383. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Higaki, D. Schullery, Y. Kawata, M. Shnyreva, C. Abrass, and K. Bomsztyk Synergistic activation of the rat laminin {gamma}1 chain promoter by the gut-enriched Kruppel-like factor (GKLF/KLF4) and Sp1 Nucleic Acids Res., June 1, 2002; 30(11): 2270 - 2279. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Expert-Bezancon, J. P. Le Caer, and J. Marie Heterogeneous Nuclear Ribonucleoprotein (hnRNP) K Is a Component of an Intronic Splicing Enhancer Complex That Activates the Splicing of the Alternative Exon 6A from Chicken beta -Tropomyosin Pre-mRNA J. Biol. Chem., May 3, 2002; 277(19): 16614 - 16623. [Abstract] [Full Text] [PDF] |
||||
|
|